DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 9, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.



More Latest News

Pain Management Clinics Application for Certificate of Exemption
November 1, 2018

Click here for the application to apply for a certificate of exemption as required by Florida’s new controlled substance law (House Bill 21). Continue reading


Annual Report & Long-Range Plan Released for the 2017-2018 Fiscal Year
November 1, 2018

The Annual Report & Long-Range Plan for the 2017-2018 Fiscal Year is now available to view online. Continue reading